Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Parexel Biotech provides the end-to-end capabilities you’ll need to succeed. We're fast, flexible, and dedicated to impacting patient lives.
Learn moreUtilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
The Regulatory Navigator
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreINTERESTED IN PARTICIPATING?
HEAR FROM REAL PATIENTS
TRIAL SITES
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
Whether you're a dedicated team of two or a biotech company with a team of more than 100, we have the agility, experience, and attitude to work side-by-side with you to develop life-changing treatments.
Fast, flexible, dedicated — we'll amplify your team's expertise with everything you need to impact patient lives, from regulatory and commercial strategy to cutting-edge trial design and execution.
At Parexel Biotech, we’ve integrated our wide breadth of services across all our business units. That gives us the speed and flexibility to deliver anything you need, right when you need it, with all your services coordinated by a single point of contact. All you need to do is reach out, and we’ll take care of it. Together, we’ll integrate scientific, clinical, regulatory, and commercial considerations early on and throughout development, so your treatment has the surest path to approval and success.
One of the most core reasons the Parexel stands out in biotech is that we integrated all of our services across all of our different business units so that we can deliver anything that the customer needs at the right time that they need it.
They're looking for service providers that can be agile and nimble, but you have to have a breadth of services in order to be agile to work with them.
There may be things that they haven't come across because they sit maybe within a discipline. They don't have the benefit of this huge multidisciplinary team that we have in the organization.
They might be an in-depth expert, but they need to collaborate with others of different disciplines, and we can bring that to them and they really see the value.
The customers are very interested in Parexel's single point of contact. We can represent all of our services with one delivery director and that way they have one person that they can go to. So, if it's a regulatory item, a logistics item, a safety item, a clinical item, that one point of contact is very important and that creates the efficiency.
The closer we get to working in a true partnership in our understanding as they're trying to develop their solution, the better we are at serving their needs. It's a pride in your job. It's a pride in your deliverable. It's a pride in that dynamic you have with the people you're working with and the customer who sits across the table from you.
So, when we show up really understanding the impact on the patient, we're all driving to the same solution, I think that really resonates.
(Source KMR Benchmarking Report 2023)
(Source KMR Benchmarking Report 2023)
Advantages
Leveraging our dedicated biotech operations group, we match your unique requirements with an experienced team that anticipates and adaptively delivers the solutions you need. We'll work closely with you to amplify your capabilities, but we’re also accountable, taking it upon ourselves to solve problems and seize opportunities as soon as they arise.
We’re passionate about the patients you serve — and your trial’s success is dependent upon them. That’s why we strive to improve clinical trial diversity and partner with patients to help shape protocols, reduce trial burden, and increase retention. By gathering input from patients, caregivers, and investigative site staff worldwide, we’re able to develop the most efficient, empathetic path forward.
No matter where you’re conducting research, we have the global reach and expertise to help you navigate competitive, regulatory, and reimbursement landscapes in all major markets, including full capabilities in China. We deliver clinical development programs worldwide to rapidly find the patients waiting for your treatment.
We’ll help you start commercial planning early to set up a clear path to investment and revenue and avoid unnecessary delays. This includes weeding out unpromising product candidates to mitigate risk and focusing on products with the best chances of success. We’ll also help you clearly articulate a coherent product value story, from start to finish, so it’s easier to raise funds, make smarter development choices, gain market share, win reimbursement, and accelerate commercialization.
Our experts in biotech
Jim Anthony
President and Global Head, Parexel Biotech
Vicky Hsu
Senior Vice President, Biotech Project Leadership, APAC
Mika Pollack
Project Director
Tasha Disney
Senior Vice President, Biotech Partnerships
Skip Sands
Senior Vice President of CCS, and Senior Medical Officer
Mwango Kashoki, M.D., M.P.H.
Senior Vice President, Global Head of Regulatory Strategy
Our experts in biotech
Jim Anthony
President and Global Head, Parexel Biotech
Vicky Hsu
Senior Vice President, Biotech Project Leadership, APAC
Mika Pollack
Project Director
Tasha Disney
Senior Vice President, Biotech Partnerships
Skip Sands
Senior Vice President of CCS, and Senior Medical Officer
Mwango Kashoki, M.D., M.P.H.
Senior Vice President, Global Head of Regulatory Strategy
Leading Insights
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Podcast
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
Sep 25, 2024
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates
Sep 25, 2024
Whitepaper
Biotech Innovation: Linking real-world data and patient insights to help demonstrate asset value
Aug 7, 2024
Video
How to de-risk drug development from the earliest stages
Jul 23, 2024
Podcast
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
Jul 16, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works
Jun 19, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Leading Insights
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Podcast
De-risking Drug Development | Episode 5: Expand the use and value of your product over time
Sep 25, 2024
Podcast
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval
Sep 25, 2024
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates
Sep 25, 2024
Whitepaper
Biotech Innovation: Linking real-world data and patient insights to help demonstrate asset value
Aug 7, 2024
Video
How to de-risk drug development from the earliest stages
Jul 23, 2024
Podcast
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept
Jul 16, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works
Jun 19, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Stay current with novel thinking and actionable insights from our experts.
